Asset Advisors Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.12M | Sell |
39,874
-280
| -0.7% | -$32.8K | 0.47% | 49 |
|
|
2026
Q1 | $4.83M | Sell |
40,154
-300
| -0.7% | -$34.6K | 0.46% | 52 |
|
|
2025
Q4 | $4.26M | Sell |
40,454
-775
| -2% | -$72.8K | 0.39% | 50 |
|
|
2025
Q3 | $3.46M | Sell |
41,229
-1,130
| -3% | -$93.1K | 0.33% | 52 |
|
|
2025
Q2 | $3.35M | Sell |
42,359
-5,853
| -12% | -$465K | 0.33% | 50 |
|
|
2025
Q1 | $4.33M | Sell |
48,212
-8,365
| -15% | -$781K | 0.45% | 48 |
|
|
2024
Q4 | $5.63M | Sell |
56,577
-8,269
| -13% | -$852K | 0.59% | 43 |
|
|
2024
Q3 | $7.36M | Sell |
64,846
-1,497
| -2% | -$178K | 0.77% | 37 |
|
|
2024
Q2 | $8.21M | Buy |
66,343
+3,133
| +5% | +$404K | 0.89% | 34 |
|
|
2024
Q1 | $8.34M | Sell |
63,210
-114
| -0.2% | -$14.1K | 0.94% | 32 |
|
|
2023
Q4 | $6.9M | Sell |
63,324
-4,324
| -6% | -$449K | 0.84% | 29 |
|
|
2023
Q3 | $6.96M | Sell |
67,648
-450
| -0.7% | -$48.5K | 0.94% | 29 |
|
|
2023
Q2 | $7.86M | Sell |
68,098
-200
| -0.3% | -$22.7K | 1% | 30 |
|
|
2023
Q1 | $7.27M | Sell |
68,298
-200
| -0.3% | -$21.6K | 0.95% | 31 |
|
|
2022
Q4 | $7.6M | Buy |
68,498
+75
| +0.1% | +$7.67K | 1% | 32 |
|
|
2022
Q3 | $5.89M | Sell |
68,423
-400
| -0.6% | -$35.7K | 0.84% | 32 |
|
|
2022
Q2 | $6.28M | Buy |
68,823
+300
| +0.4% | +$26.6K | 0.86% | 32 |
|
|
2022
Q1 | $5.62M | Buy |
68,523
+325
| +0.5% | +$25.6K | 0.63% | 41 |
|
|
2021
Q4 | $5.23M | Sell |
68,198
-200
| -0.3% | -$15.9K | 0.53% | 44 |
|
|
2021
Q3 | $5.14M | Sell |
68,398
-1,300
| -2% | -$98.9K | 0.57% | 43 |
|
|
2021
Q2 | $5.42M | Sell |
69,698
-3,608
| -5% | -$268K | 0.6% | 45 |
|
|
2021
Q1 | $5.34M | Sell |
73,306
-38,455
| -34% | -$2.84M | 0.62% | 41 |
|
|
2020
Q4 | $8.72M | Buy |
111,761
+4,968
| +5% | +$380K | 1.13% | 31 |
|
|
2020
Q3 | $8.45M | Buy |
106,793
+4,454
| +4% | +$349K | 1.28% | 27 |
|
|
2020
Q2 | $7.55M | Buy |
102,339
+2,555
| +3% | +$192K | 1.21% | 31 |
|
|
2020
Q1 | $7.33M | Buy |
99,784
+6,513
| +7% | +$512K | 1.36% | 27 |
|
|
2019
Q4 | $8M | Buy |
93,271
+1,162
| +1% | +$95.4K | 1.16% | 31 |
|
|
2019
Q3 | $7.4M | Buy |
92,109
+688
| +0.8% | +$55.1K | 1.18% | 29 |
|
|
2019
Q2 | $7.32M | Sell |
91,421
-1,077
| -1% | -$82.5K | 1.23% | 26 |
|
|
2019
Q1 | $7.34M | Sell |
92,498
-340
| -0.4% | -$25.4K | 1.31% | 26 |
|
|
2018
Q4 | $6.77M | Hold |
92,838
| – | – | 1.34% | 25 |
|
|
2018
Q3 | $6.28M | Buy |
+92,838
| New | +$5.91M | 1.04% | 33 |
|
Other funds holding MRK
Asset Advisors Investment Management's MRK Position: Q2 2026 in Review
Asset Advisors Investment Management reduced its Merck (MRK) stake by 0.7% in Q2 2026, selling an estimated $32.8K and leaving 39,874 shares worth $5.12M. The position accounts for 0.47% of the portfolio, ranked #49.
Asset Advisors Investment Management first reported a position in MRK in Q3 2018 and has held it in 32 quarters since. The position peaked at $8.72M in Q4 2020. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Asset Advisors Investment Management held 39,874 shares of Merck worth $5.12M as of Q2 2026.
- Asset Advisors Investment Management sold 280 Merck shares in Q2 2026, an estimated $32.8K.
- Merck made up 0.47% of Asset Advisors Investment Management's portfolio in Q2 2026, its #49 holding.
- Asset Advisors Investment Management first reported a position in Merck in Q3 2018 and has held it in 32 quarters since.
- Asset Advisors Investment Management's Merck position peaked at $8.72M in Q4 2020.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Asset Advisors Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.